158 related articles for article (PubMed ID: 10754499)
1. Loss of heterozygosity analysis on chromosome 5p defines 5p13-12 as the critical region involved in tumor progression of bladder carcinomas.
Böhm M; Kleine-Besten R; Wieland I
Int J Cancer; 2000 Mar; 89(2):194-7. PubMed ID: 10754499
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity on chromosome 5p13-12 predicts adverse prognosis in advanced bladder cancer independent of tumor stage and grade.
Böhm M; Wieland I; Schmidt C; Rubben H; Allhoff EP
J Urol; 2002 Dec; 168(6):2655-8. PubMed ID: 12442004
[TBL] [Abstract][Full Text] [Related]
3. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
4. Role of loss of heterozygosity on chromosomes 8 and 9 in the development and progression of cancer bladder.
Abdel Wahab AH; Abo-Zeid HI; El-Husseini MI; Ismail M; El-Khor AM
J Egypt Natl Canc Inst; 2005 Dec; 17(4):260-9. PubMed ID: 17102820
[TBL] [Abstract][Full Text] [Related]
5. [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].
Zheng S; Zhang J; Di X; Xiao Z; Wang D; Li C; He Z; Han N; Guo S; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):161-3. PubMed ID: 11953150
[TBL] [Abstract][Full Text] [Related]
6. Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer.
Kagan J; Liu J; Stein JD; Wagner SS; Babkowski R; Grossman BH; Katz RL
Oncogene; 1998 Feb; 16(7):909-13. PubMed ID: 9484782
[TBL] [Abstract][Full Text] [Related]
7. Allelic changes at multiple regions of chromosome 5 are associated with progression of urinary bladder cancer.
von Knobloch R; Bugert P; Jauch A; Kälble T; Kovacs G
J Pathol; 2000 Feb; 190(2):163-8. PubMed ID: 10657014
[TBL] [Abstract][Full Text] [Related]
8. Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade.
Wada T; Louhelainen J; Hemminki K; Adolfsson J; Wijkström H; Norming U; Borgström E; Hansson J; Sandstedt B; Steineck G
Clin Cancer Res; 2000 Feb; 6(2):610-5. PubMed ID: 10690546
[TBL] [Abstract][Full Text] [Related]
9. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
10. Allelic deletion mapping on chromosome 5 in human carcinomas.
Wieland I; Böhm M; Arden KC; Ammermüller T; Bogatz S; Viars CS; Rajewsky MF
Oncogene; 1996 Jan; 12(1):97-102. PubMed ID: 8552404
[TBL] [Abstract][Full Text] [Related]
11. High frequency loss of heterozygosity in the region of the DBH locus in bladder cancer.
Yang X; Shen P; Yao K; Mi Z; Liu S; Zhang H; Wang D; Liu C; Liu H
Chin Med J (Engl); 2000 Feb; 113(2):117-9. PubMed ID: 11775532
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M
Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830
[TBL] [Abstract][Full Text] [Related]
13. [Refined mapping of heterozygosity loss on chromosome 5p15 in sporadic colorectal cancer].
Xu SF; Li DP; Peng ZH
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):413-7. PubMed ID: 19024513
[TBL] [Abstract][Full Text] [Related]
14. Allelotype of human bladder cancer.
Knowles MA; Elder PA; Williamson M; Cairns JP; Shaw ME; Law MG
Cancer Res; 1994 Jan; 54(2):531-8. PubMed ID: 8275491
[TBL] [Abstract][Full Text] [Related]
15. Refinement of heterozygosity loss on chromosome 5p15 in sporadic colorectal cancer.
Xu SF; Peng ZH; Li DP; Qiu GQ; Zhang F
World J Gastroenterol; 2003 Aug; 9(8):1713-8. PubMed ID: 12918106
[TBL] [Abstract][Full Text] [Related]
16. Allelic loss on chromosome 1 is associated with tumor progression of cervical carcinoma.
Cheung TH; Chung TK; Poon CS; Hampton GM; Wang VW; Wong YF
Cancer; 1999 Oct; 86(7):1294-8. PubMed ID: 10506716
[TBL] [Abstract][Full Text] [Related]
17. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.
Knowles MA; Shaw ME; Proctor AJ
Oncogene; 1993 May; 8(5):1357-64. PubMed ID: 8097582
[TBL] [Abstract][Full Text] [Related]
18. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas.
Utada Y; Haga S; Kajiwara T; Kasumi F; Sakamoto G; Nakamura Y; Emi M
Cancer; 2000 Mar; 88(6):1410-6. PubMed ID: 10717624
[TBL] [Abstract][Full Text] [Related]
19. Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival.
Arribas R; Ribas M; Risques RA; Masramon L; Tórtola S; Marcuello E; Aiza G; Miró R; Capellà G; Peinado MA
Clin Cancer Res; 1999 Nov; 5(11):3454-9. PubMed ID: 10589758
[TBL] [Abstract][Full Text] [Related]
20. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
